Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor–Specific Antibodies

Transplantation Journal ◽

10.1097/tp.0000000000002913 ◽

2020 ◽

Vol 104 (4) ◽

pp. 881-887 ◽

Author(s):

Scott Davis ◽

Jane Gralla ◽

Patrick Klem ◽

Erik Stites ◽

Alexander Wiseman ◽

...

Keyword(s):

Therapeutic Range ◽

De Novo ◽

Specific Antibodies ◽

Time In Therapeutic Range ◽

Intrapatient Variability ◽

Donor Specific Antibodies

Download Full-text

Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation

American Journal of Transplantation ◽

10.1111/ajt.14504 ◽

2017 ◽

Vol 18 (4) ◽

pp. 907-915 ◽

Author(s):

Scott Davis ◽

Jane Gralla ◽

Patrick Klem ◽

Suhong Tong ◽

Gina Wedermyer ◽

...

Keyword(s):

Kidney Transplantation ◽

Therapeutic Range ◽

De Novo ◽

Specific Antibodies ◽

Time In Therapeutic Range ◽

Donor Specific Antibodies

Download Full-text

Association between dd‐cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort

Clinical Transplantation ◽

10.1111/ctr.14402 ◽

2021 ◽

Author(s):

D Sawinski ◽

S Mehta ◽

T Alhamad ◽

JS Bromberg ◽

B Fischbach ◽

...

Keyword(s):

De Novo ◽

Specific Antibodies ◽

Donor Specific Antibodies ◽

Download Full-text

Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal

Transplantation Direct ◽

10.1097/txd.0000000000001155 ◽

2021 ◽

Vol 7 (6) ◽

pp. e698

Author(s):

Dana R. Pierce ◽

Patricia West-Thielke ◽

Zahraa Hajjiri ◽

Sujata Gaitonde ◽

Ivo Tzvetanov ◽

...

Keyword(s):

Renal Transplant ◽

Therapeutic Range ◽

Clinical Implications ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Corticosteroid Withdrawal ◽

Time In Therapeutic Range ◽

Intrapatient Variability

Download Full-text

Persistence of De Novo Donor Specific Antibodies Results in Higher Rates of Acute Rejection and Graft Loss in Renal Transplant Recipients With Stable Renal Function.

Transplantation Journal ◽

10.1097/00007890-201407151-00376 ◽

2014 ◽

Vol 98 ◽

pp. 122-123

Author(s):

J. DeVos ◽

R. Knight ◽

S. Patel ◽

A. Islam ◽

L. Teeter ◽

...

Keyword(s):

Renal Function ◽

Renal Transplant ◽

Acute Rejection ◽

De Novo ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Specific Antibodies ◽

Stable Renal Function ◽

Donor Specific Antibodies

Download Full-text

SO016INFLAMMATION IN EARLY KIDNEY ALLOGRAFT SURVEILLANCE BIOPSIES WITH AND WITHOUT ASSOCIATED TUBULO-INTERSTITIAL CHRONIC DAMAGE AS A PREDICTOR OF FIBROSIS PROGRESSION AND DEVELOPMENTOF DE NOVO DONOR SPECIFIC ANTIBODIES

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfw119.05 ◽

2016 ◽

Vol 31 (suppl_1) ◽

pp. i7-i7

Author(s):

Clara Garcia-Carro ◽

Christina Dörje ◽

Anders Åsberg ◽

Karsten Midvetdt ◽

Hallvard Holdaas ◽

...

Keyword(s):

De Novo ◽

Kidney Allograft ◽

Specific Antibodies ◽

Fibrosis Progression ◽

Donor Specific Antibodies

Download Full-text

Development and outcomes of de novo donor‐specific antibodies in low, moderate, and high immunological risk kidney transplant recipients

American Journal of Transplantation ◽

10.1111/ajt.15754 ◽

2020 ◽

Vol 20 (5) ◽

pp. 1351-1364 ◽

Author(s):

Susan S. Wan ◽

Steven J. Chadban ◽

Narelle Watson ◽

Kate Wyburn

Keyword(s):

Kidney Transplant ◽

De Novo ◽

Transplant Recipients ◽

Kidney Transplant Recipients ◽

Specific Antibodies ◽

Donor Specific Antibodies

Download Full-text

De Novo Donor Specific Antibodies in Renal and Lung Transplantation:A Comparison of Incidence, Risk Factors, and Outcomes.

Transplantation Journal ◽

10.1097/00007890-201407151-02740 ◽

2014 ◽

Vol 98 ◽

pp. 802

Author(s):

R. Knight ◽

J. DeVos ◽

A. Islam ◽

S. Patel ◽

S. Jyothula ◽

...

Keyword(s):

Risk Factors ◽

De Novo ◽

Specific Antibodies ◽

Incidence Risk ◽

Donor Specific Antibodies

Download Full-text

BK Viremia (BKV) Persisting After Immunosuppression Reduction Does Not Increase Intermediate-Term Graft Loss But Is Associated With De Novo Donor Specific Antibodies (DSA).

Transplantation Journal ◽

10.1097/00007890-201407151-00262 ◽

2014 ◽

Vol 98 ◽

pp. 84-85

Author(s):

D. Sawinski ◽

K. Forde ◽

J. Trofe-Clark ◽

P. Patel ◽

B. Olivera ◽

...

Keyword(s):

De Novo ◽

Specific Antibodies ◽

Donor Specific Antibodies

Download Full-text

SAT-372-High prevalence of anti HLA Class II de novo donor-specific antibodies during rejection after liver transplantation

Journal of Hepatology ◽

10.1016/s0618-8278(19)31592-0 ◽

2019 ◽

Vol 70 (1) ◽

pp. e799

Author(s):

Jordi Colmenero ◽

Pablo Ruiz ◽

Nayelli Flores ◽

Monica Vasquez ◽

Garcia Raquel ◽

...

Keyword(s):

Liver Transplantation ◽

De Novo ◽

Class Ii ◽

Hla Class Ii ◽

Specific Antibodies ◽

High Prevalence ◽

Donor Specific Antibodies

Download Full-text

Risk of Post-Transplant De Novo Donor Specific Antibodies in Patients Receiving Transfusions Perioperatively

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2018.01.1099 ◽

2018 ◽

Vol 37 (4) ◽

pp. S423-S424

Author(s):

I. Mahoney ◽

A. Young ◽

N. Shekiladze ◽

A. Morris ◽

D. Gupta ◽

...

Keyword(s):

De Novo ◽

Specific Antibodies ◽

Post Transplant ◽

Donor Specific Antibodies

Download Full-text